Pharmacokinetic Models [Design Issues]

posted by venu  – Mumbai, India, 2007-02-14 06:00 (7061 d 22:48 ago) – Posting: # 515
Views: 5,732

Hi,

In BA/BE studies, why only 2x2 crossover design noncompartmental models are used in most of the pilot and pivotal studies? :-)

When can you use the compartmental models in the BA/BE stuides? Does the use of these compartmental models depend on the nature of the generic drugs.

Please if you could provide more information in detail regarding the questions mentioned above. :-)

Venu

Best Regards,
Ms. Vandana Panchal
Biostatistician
Mumbai
India

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
125 visitors (0 registered, 125 guests [including 19 identified bots]).
Forum time: 05:49 CEST (Europe/Vienna)

Always listen to experts.
They’ll tell you what can’t be done and why.
Then do it.    Robert A. Heinlein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5